Upgrade to SI Premium - Free Trial

Zymeworks (ZYME)

23.54 -0.51 (2.12%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (7/30/26)

Latest Headlines

Zymeworks to Report Second Quarter 2026 Financial Results on August 6, 2026 July 16, 2026 6:00 AM - StreetInsider H.C. Wainwright Downgrades Theravance Biopharma (TBPH) to Neutral July 7, 2026 7:37 AM - StreetInsider Zymeworks (ZYME) PT Raised to $31 at Truist Securities July 7, 2026 7:09 AM - StreetInsider Form 4 Zymeworks Inc. For: Jul 06 Filed by: Hollywood Mark July 6, 2026 5:29 PM - SEC Filing B. Riley: 'Aggressively Buying the ZYME Dip' June 29, 2026 10:27 AM - StreetInsider BTIG Downgrades Theravance Biopharma (TBPH) to Neutral June 29, 2026 9:20 AM - StreetInsider Jones Trading Downgrades Theravance Biopharma (TBPH) to Hold June 29, 2026 8:34 AM - StreetInsider Form 8-K Zymeworks Inc. For: Jun 28 June 29, 2026 7:20 AM - SEC Filing Zymeworks (ZYME) Reiterated at Buy by Stifel: 'Significantly Undervalued' June 29, 2026 7:19 AM - StreetInsider Zymeworks to buy Theravance Biopharma for $17 per share June 29, 2026 6:00 AM - StreetInsider Zymeworks to Acquire Theravance Biopharma, Inc. June 29, 2026 6:00 AM - StreetInsider H.C. Wainwright Reiterates Buy Rating on Zymeworks (ZYME) June 22, 2026 6:59 AM - StreetInsider Gandeeva and Zymeworks partner on cryo-EM antibody structure work June 18, 2026 8:05 AM - StreetInsider Gandeeva and Zymeworks Use Cryo-EM to Accelerate Antibody Drug Discovery June 18, 2026 8:00 AM - PR NewsWire Zymeworks (ZYME) Reiterated at Market Outperform by Citizens on ZW191 Efficacy Data June 16, 2026 5:25 AM - StreetInsider Zymeworks reports phase 1 data for cancer drug ZW191 June 14, 2026 6:05 PM - StreetInsider Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting ADC ZW191 at ESMO Gynaecological Cancers Congress 2026 June 14, 2026 6:05 PM - StreetInsider Truist Securities Assumes Zymeworks (ZYME) at Buy June 9, 2026 6:08 AM - StreetInsider H.C. Wainwright Reiterates Buy Rating on Zymeworks (ZYME) June 3, 2026 6:52 AM - StreetInsider Form 4 Zymeworks Inc. For: May 13 Filed by: Schneider Paul R May 15, 2026 5:00 PM - SEC Filing Form 3 Zymeworks Inc. For: May 13 Filed by: Schneider Paul R May 15, 2026 4:55 PM - SEC Filing Form SCHEDULE 13G/A Zymeworks Inc. Filed by: Rubric Capital Management LP May 15, 2026 4:15 PM - SEC Filing Form 8-K Zymeworks Inc. For: May 14 May 14, 2026 4:30 PM - SEC Filing Zymeworks authorizes $125 million share repurchase program May 14, 2026 4:05 PM - StreetInsider Zymeworks Announces Share Repurchase Program of up to $125 Million of its Common Stock May 14, 2026 4:05 PM - StreetInsider Zymeworks Announces Participation in Upcoming Investor Conferences May 13, 2026 6:00 AM - StreetInsider Zymeworks (ZYME) Reiterated at Market Outperform by Citizens After Q1 Results May 11, 2026 4:19 AM - StreetInsider Zymeworks (ZYME) PT Raised to $34 at Wells Fargo May 8, 2026 6:55 AM - StreetInsider Zymeworks (ZYME) Misses Q1 EPS by 59c May 7, 2026 4:41 PM - StreetInsider Form 10-Q Zymeworks Inc. For: Mar 31 May 7, 2026 4:18 PM - SEC Filing Form 8-K Zymeworks Inc. For: May 07 May 7, 2026 4:13 PM - SEC Filing Zymeworks Provides Corporate Update and Reports First Quarter 2026 Financial Results May 7, 2026 4:06 PM - Globe NewsWire Zymeworks Provides Corporate Update and Reports First Quarter 2026 Financial Results May 7, 2026 4:05 PM - StreetInsider H.C. Wainwright Reiterates Buy Rating on Zymeworks (ZYME) April 28, 2026 6:43 AM - StreetInsider H.C. Wainwright Reiterates Buy Rating on Zymeworks (ZYME) April 23, 2026 6:59 AM - StreetInsider Full Article List